Luckily, the hiring process proceeded smoothly and Charles van Zyl joined as chief executive from Belgian pharma company UCB ...

HonorHealth announced the creation of its new international Center for Translational Science. Sanofi said it will repurchase $5.2 billion of stock and grow profits faster this year as the drugmaker ...

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...

The RONA Foundation, which oversees the philanthropic activities of RONA inc., one of Canada's leading home improvement retailers operating and servicing some 425?corporate and affiliated stores, ...

Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.

Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") of a class action securities ...

Liraglutide is currently sold only in an injectable form under the brand names Saxenda® and Victoza®, both manufactured by Novo Nordisk®. Despite the launch ... scientific discovery, the patent ...

On Tuesday, his company, Variant Bio, based in Seattle, announced a $50 million collaboration with drugmaker Novo Nordisk to develop ... on their patent application as co-inventors, nor did ...

KELOWNA, BC / ACCESS Newswire / January 30, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW), (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to provi ...

While the deals done this week are important for the future direction of the industry – US company Gilead (US:GILD) inked the biggest, paying up to $1.7bn for Leo Pharma’s range of pre-clinical ...

Robert F. Kennedy Jr. faces high-stakes Senate hearings as he seeks confirmation for Health Secretary. This live blog is now ...

Dewpoint Therapeutics’ second development candidate, DPTX3496 is an oral, small molecule acting via a novel condensate-modulating mechanism of ...